Finance

Novavax Coronavirus Vaccine Candidate Shows 96% Efficacy With Original Strain, 86% Against U.K. Variant


The efficacy was far lower against the South African variant, though. Will Novavax’s (NASDAQ:NVAX) NVX-CoV2373 be the next coronavirus vaccine to win …

Read more

Show More

Related Articles

Back to top button